Common triggers include spicy, fatty, acidic, or heavily seasoned foods
These pharmaceutical drugs have since gained approval for the treatment of obesity
The key variable was not the exact timeline but whether the taper was gradual enough for the individual to develop compensatory habits before appetite fully returned
Body weight also mattersindividuals with higher BMI may require longer treatment duration to achieve proportional weight loss, though the percentage of body weight lost can be substantial over time
This suit is not part of the consolidated GLP-1 MDL in the Eastern District of Pennsylvania, where most Ozempic and Mounjaro claims focus on gastrointestinal side effects like gastroparesis and ileus
Competitive Landscape Analysis The global GLP-1 analogues market comprises of several well-established and emerging players, including Eli Lilly and Company